5P Tumor microenvironment cellular crosstalk predicts response to adoptive TIL therapy in melanoma patients. (December 2022) - Dangaj, D.; Barras, D.; Ghisoni, E.; Chiffelle, J.; Orcurto, A.; Dagher, J.; Fahr, N.; Dafni, U.; Sempoux, C.; Michielin, O.A.; Trueb, L.; Harari, A.; et al.